Sylvie Roques

459 total citations
8 papers, 386 citations indexed

About

Sylvie Roques is a scholar working on Genetics, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Sylvie Roques has authored 8 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 3 papers in Reproductive Medicine and 2 papers in Molecular Biology. Recurrent topics in Sylvie Roques's work include Ovarian cancer diagnosis and treatment (3 papers), Estrogen and related hormone effects (2 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (1 paper). Sylvie Roques is often cited by papers focused on Ovarian cancer diagnosis and treatment (3 papers), Estrogen and related hormone effects (2 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (1 paper). Sylvie Roques collaborates with scholars based in France. Sylvie Roques's co-authors include Frédéric Bibeau, S. Gourgou-Bourgade, Carine Chavey, Daniel Laune, Gwendal Lazennec, Florence Boissière‐Michot, Pierre‐Jean Lamy, Philippe Berta, Safia Malki and Cécile Notarnicola and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Letters and Breast Cancer Research.

In The Last Decade

Sylvie Roques

7 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Roques France 5 216 153 139 90 56 8 386
Shuwei Liang Australia 5 139 0.6× 201 1.3× 123 0.9× 48 0.5× 62 1.1× 5 311
André Wendindondé Nana Taiwan 12 137 0.6× 158 1.0× 59 0.4× 85 0.9× 28 0.5× 12 357
Bingmu Fang China 9 141 0.7× 136 0.9× 98 0.7× 83 0.9× 24 0.4× 20 339
Domenico Zito Italy 8 117 0.5× 164 1.1× 78 0.6× 123 1.4× 111 2.0× 12 427
Tenghua Yu China 10 157 0.7× 213 1.4× 41 0.3× 127 1.4× 139 2.5× 30 380
Chun‐Fui Lai United Kingdom 10 151 0.7× 228 1.5× 50 0.4× 110 1.2× 132 2.4× 13 421
Brooke Ancrile United States 3 224 1.0× 166 1.1× 116 0.8× 79 0.9× 12 0.2× 7 399
Ritu Arora United States 8 150 0.7× 152 1.0× 109 0.8× 90 1.0× 18 0.3× 15 351
David L. Elion United States 10 136 0.6× 227 1.5× 212 1.5× 55 0.6× 32 0.6× 11 411
Hexiao Tang China 9 105 0.5× 178 1.2× 71 0.5× 101 1.1× 31 0.6× 24 326

Countries citing papers authored by Sylvie Roques

Since Specialization
Citations

This map shows the geographic impact of Sylvie Roques's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Roques with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Roques more than expected).

Fields of papers citing papers by Sylvie Roques

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Roques. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Roques. The network helps show where Sylvie Roques may publish in the future.

Co-authorship network of co-authors of Sylvie Roques

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Roques. A scholar is included among the top collaborators of Sylvie Roques based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Roques. Sylvie Roques is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lamy, Pierre‐Jean, Célia Touraine, Caroline Mollévi, et al.. (2017). Kinetics of HE4 and CA125 markers in metastatic ovarian cancer: The META4 study.. Journal of Clinical Oncology. 35(15_suppl). e17059–e17059. 2 indexed citations
2.
Lamy, Pierre‐Jean, et al.. (2015). Next-Generation Genotyping by Digital PCR to Detect and Quantify the BRAF V600E Mutation in Melanoma Biopsies. Journal of Molecular Diagnostics. 17(4). 366–373. 32 indexed citations
3.
Lamy, Pierre‐Jean, Diégo Tosi, Caroline Mollévi, et al.. (2013). Evaluation of (-2)proPSA in combination with total PSA and free PSA for the early detection of prostate cancer. Annales de biologie clinique. 71(5). 537–544. 1 indexed citations
4.
Jacot, William, et al.. (2012). Iron metabolism in breast cancer: knowledge and future. Annales de biologie clinique. 70(4). 387–396. 7 indexed citations
5.
Lamy, Pierre‐Jean, et al.. (2010). HE4, un nouveau marqueur des cancers épithéliaux ovariens : évaluation des performances analytiques HE4, a novel marker for epithelial ovarian cancer: evaluation of analytical performances. 1 indexed citations
6.
Lamy, Pierre‐Jean, et al.. (2010). HE4, un nouveau marqueur des cancers épithéliaux ovariens: évaluation des performances analytiques. Annales de biologie clinique. 68(3). 325–329. 4 indexed citations
7.
Chavey, Carine, Frédéric Bibeau, S. Gourgou-Bourgade, et al.. (2007). Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Research. 9(1). R15–R15. 294 indexed citations
8.
Malki, Safia, Frédéric Bibeau, Cécile Notarnicola, et al.. (2007). Expression and biological role of the prostaglandin D synthase/SOX9 pathway in human ovarian cancer cells. Cancer Letters. 255(2). 182–193. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026